Syphilis

By /

Introduction

  • Syphilis is a chronic sexually transmitted infection (STI) caused by the spirochete bacterium Treponema pallidum.
  • It is one of the most important sexually transmitted diseases worldwide and can affect multiple organ systems if left untreated.
  • Syphilis is known for its distinct clinical stages and ability to mimic many other diseases, earning it the title “The Great Imitator.”

Transmission occurs mainly through:

  • Sexual contact
  • Transplacental transmission (congenital syphilis)
  • Rarely through blood transfusion or direct contact with lesions

Causative Organism

Treponema pallidum

Features:

  • Thin, spiral-shaped spirochete
  • Gram-negative–like organism
  • Highly motile with corkscrew movement
  • Cannot be cultured on ordinary laboratory media
  • Extremely sensitive to drying, heat, and disinfectants

Morphology

  • Slender, tightly coiled spiral organism
  • Length: 6–15 µm
  • Possesses axial filaments (endoflagella) for motility
  • Best visualized by:
    • Dark-field microscopy
    • Silver impregnation staining
  • Not easily seen on routine Gram staining

Pathogenesis

Mechanism of Infection

  1. Entry through microscopic abrasions in skin or mucosa during sexual contact
  2. Local multiplication at the site of entry
  3. Spread through lymphatics and bloodstream
  4. Dissemination to multiple organs

The organism causes:

  • Chronic inflammatory response
  • Endarteritis (vascular inflammation)
  • Tissue destruction due to immune-mediated injury

Clinical Stages of Syphilis

1. Primary Syphilis

Incubation Period

  • Usually 3 weeks (range 10–90 days)

Clinical Features

  • Development of a painless chancre
  • Firm, indurated ulcer with clean base
  • Commonly present on:
    • Genitalia
    • Cervix
    • Oral cavity

Associated Findings

  • Regional non-tender lymphadenopathy

Important Point

  • Lesion heals spontaneously within 3–6 weeks even without treatment.

2. Secondary Syphilis

Occurs weeks to months after primary infection due to systemic dissemination.

Clinical Features

  • Fever
  • Malaise
  • Sore throat
  • Generalized lymphadenopathy

Skin Manifestations

  • Symmetrical maculopapular rash
  • Rash characteristically involves:
    • Palms
    • Soles

Other Lesions

  • Condyloma lata
  • Mucous patches in oral cavity
  • Patchy alopecia

Infectivity

  • Highly infectious stage

3. Latent Syphilis

  • Asymptomatic phase
  • Positive serological tests
  • Divided into:
    • Early latent (<1 year)
    • Late latent (>1 year)

Patients remain infectious in early latent stage.

4. Tertiary Syphilis

Develops years after untreated infection.

A. Cardiovascular Syphilis

  • Aortitis
  • Ascending aortic aneurysm
  • Aortic valve insufficiency

B. Neurosyphilis

May occur at any stage.

Manifestations

  • Meningitis
  • Tabes dorsalis
  • General paresis
  • Dementia

C. Gummatous Syphilis

  • Granulomatous destructive lesions called gummas
  • Affect:
    • Skin
    • Bone
    • Liver

 

 

Sample Collection

Specimen Types

For diagnosing syphilis, the following specimens are typically collected:

  1. Blood Samples:
    • Venipuncture is performed to collect serum for serological testing.
  2. Lesion Samples:
    • Exudate from an ulcer or lesion can be collected for direct testing.
  3. Cerebrospinal Fluid (CSF):
    • Collected via lumbar puncture for cases suspected to involve the central nervous system (CNS).
  4. Lymph Node Aspirates:
    • Occasionally, aspirates from lymph nodes involved in secondary syphilis can be tested.

Laboratory Techniques

Serological Tests

Serological tests are the cornerstone of syphilis diagnosis. They are categorized into two main types: non-treponemal tests and treponemal tests.

Non-Treponemal Tests

These tests detect non-specific antibodies produced due to tissue damage and are not specific to Treponema pallidum.

  • Common Tests:
    • Rapid Plasma Reagin (RPR):
      • Method: Serum is mixed with cardiolipin antigen and monitored for agglutination.
      • Interpretation: A positive result indicates the presence of antibodies but requires confirmation with a treponemal test.
    • Venereal Disease Research Laboratory (VDRL):
      • Method: Similar to RPR, used primarily for detecting neurosyphilis in CSF.
      • Limitations: This may yield false-positive results due to conditions like pregnancy, other infections, and autoimmune disorders.

Treponemal Tests

These tests detect antibodies against Treponema pallidum and are more specific than non-treponemal tests.

  • Common Tests:
    • Enzyme Immunoassays (EIA):
      • Method: Serological test that detects treponemal antibodies. They are quantitative and can indicate both active and past infections.
    • Fluorescent Treponemal Antigen Absorption (FTA-ABS):
      • Method: More sensitive and specific; it involves exposing serum to treponemal antigens and observing for fluorescence.
      • Interpretation: Remains positive for life, indicating prior exposure to the bacterium, but does not reflect active disease.

Direct Detection Methods

 Darkfield Microscopy

  • Purpose: Direct visualization of Treponema pallidum from lesions.
  • Procedure: A sample from a chancre is examined under darkfield illumination, which allows for identifying the motile spirochetes.
  • Limitations: Requires skilled personnel and is less commonly available in clinical settings.

Polymerase Chain Reaction (PCR)

  • Description: Detects specific Treponema pallidum DNA in clinical specimens.
  • Utility: Particularly useful in cases where serological tests are inconclusive or for early detection in primary syphilis.
  • Advancement: Highly sensitive and specific, allowing for rapid diagnosis.

Cerebrospinal Fluid Analysis

For patients suspected of having neurosyphilis:

  • VDRL Test: A positive result in CSF is a strong indicator of neurosyphilis.
  • Cell Count: Elevated white blood cell count with a lymphocytic predominance may suggest CNS involvement.
  • Protein Level: Increased protein concentration can indicate inflammation or infection.

Interpretation of Results

Serological Testing

  • Non-Treponemal Tests:
    • Positive Result: Suggests active syphilis or past infection. Follow-up with treponemal testing is necessary.
    • Negative Result: Does not exclude syphilis, especially in early or late stages.
  • Treponemal Tests:
    • Positive Result: Confirms exposure to Treponema pallidum. Remains positive for life, even after treatment.
    • Negative Result: Indicates no current or past infection.

Direct Detection

  • Darkfield Microscopy:
    • Positive Result: Indicates active syphilis, particularly useful in primary stages.
  • PCR:
    • Positive Result: Confirms active infection with Treponema pallidum.

CSF Analysis

  • Positive VDRL: Strong evidence for neurosyphilis.
  • Increased WBC and protein in CSF: Suggestive of CNS involvement.

Clinical Implications

Treatment

  • Penicillin G: The primary treatment for all stages of syphilis. Dosage and duration vary based on the stage:
    • Primary/Secondary Syphilis: Benzathine penicillin G, 2.4 million units intramuscularly in a single dose.
    • Latent Syphilis: Treatment may require a longer course, depending on the duration.
    • Neurosyphilis: Aqueous penicillin G, administered intravenously for 10 to 14 days.

Monitoring Response

  • Non-treponemal tests (e.g., RPR, VDRL) monitor treatment response, with a fourfold titer decline indicating effective therapy.

Public Health Considerations

  • Syphilis is a notifiable disease; healthcare providers must report cases to public health authorities.
  • Public health campaigns should focus on education about safe sex practices, the importance of regular testing, and access to treatment.

Challenges in Diagnosis

  • Stigma: Patients may avoid testing due to the stigma associated with STIs.
  • Clinical Overlap: Symptoms can mimic other infections, leading to misdiagnosis.
  • Access to Services: Limited access to diagnostic services in resource-constrained settings can delay diagnosis and treatment.

Advances in Syphilis Diagnostics

Emerging Technologies

  • Rapid Diagnostic Tests (RDTs): Point-of-care tests that provide quick results and can facilitate immediate treatment. Some RDTs can differentiate between treponemal and non-treponemal antibodies.

Genomic Studies

  • Whole Genome Sequencing: Provides insights into the epidemiology of syphilis, antibiotic resistance patterns, and potential vaccine development.

Research Directions

  • Ongoing research is focused on developing more sensitive serological tests, improving point-of-care diagnostics, and exploring potential vaccines.

Vaccination Efforts

  • While no vaccine is currently available, research is being conducted to develop effective vaccines against syphilis.

 

Scroll to Top
Enable Notifications OK No thanks